Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Current Liabilities for the year ending August 31, 2024: USD 20.01 M

Cannara Biotech Inc. Current Liabilities is USD 20.01 M for the year ending August 31, 2024, a 27.70% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Cannara Biotech Inc. Current Liabilities for the year ending August 31, 2023 was USD 15.67 M, a 73.58% change year over year.
  • Cannara Biotech Inc. Current Liabilities for the year ending August 31, 2022 was USD 9.03 M, a 66.67% change year over year.
  • Cannara Biotech Inc. Current Liabilities for the year ending August 31, 2021 was USD 5.42 M, a 103.33% change year over year.
  • Cannara Biotech Inc. Current Liabilities for the year ending August 31, 2020 was USD 2.66 M, a -30.04% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email